Financial statements Antidotum Group
Balance sheet data of ANTIDOTUM GROUP
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 1 116 570,19 | 95 913,57 |
| A. Fixed assets | 593 671,43 | 87 038,47 |
| B. Current assets | 522 898,76 | 8 875,10 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 1 116 570,19 | 95 913,57 |
| A. Equity | 775 284,60 | 15 326,39 |
| B. Liabilities and provisions for liabilities | 341 285,59 | 80 587,18 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 341 285,59 | 80 587,18 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.